Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Effects of Microdosed Resistance Training During Physical Education on Health-Related Fitness in Adolescents

21. september 2026 opdateret af: Dawid Koźlenia, Wroclaw University of Health and Sport Sciences

Effects of Microdosed Resistance Training During Physical Education Lessons on Health-Related Fitness in School Adolescents

This study will examine whether short bouts of resistance training incorporated into physical education lessons can improve health-related physical fitness in secondary school students aged 15-16 years.

A total of 264 students will participate in two successive cohorts. School classes, rather than individual students, will be randomly assigned to study groups. In the first cohort, three resistance-training programs using low, moderate, or high training loads will be compared with usual physical education. The program producing the most consistent beneficial changes will then be tested in a new group of students in the second cohort and compared with usual physical education.

Each training program will last eight weeks. Participants will be assessed before the intervention, halfway through it, immediately after it, and eight weeks after it ends. Assessments will include body composition, blood pressure, cardiorespiratory fitness, muscular fitness, jumping performance, trunk muscular endurance, and sprint performance.

The study will evaluate both average changes in each group and the proportion of students showing improvements greater than the expected measurement error of the tests.

Studieoversigt

Status

Status

Angiver den aktuelle rekrutteringsstatus eller den udvidede adgangsstatus.
Ikke rekrutterer endnu

Betingelser

Betingelser

Den sygdom, lidelse, syndrom, sygdom eller skade, der undersøges. På ClinicalTrials.gov kan tilstande også omfatte andre sundhedsrelaterede problemer, såsom levetid, livskvalitet og sundhedsrisici.

Intervention / Behandling

Intervention / Behandling

En proces eller handling, der er i fokus for en klinisk undersøgelse. Interventioner omfatter lægemidler, medicinsk udstyr, procedurer, vacciner og andre produkter, der enten er til undersøgelse eller allerede er tilgængelige. Interventioner kan også omfatte ikke-invasive tilgange, såsom uddannelse eller ændring af kost og motion.

Detaljeret beskrivelse

This school-based study is designed as a two-stage, cluster-randomized controlled trial consisting of an exploratory cohort followed by a confirmatory cohort. The school class is the unit of randomization. Planned enrollment is 132 students in each cohort, for a total of 264 participants.

In Cohort I, participating classes will be randomized in a 1:1:1:1 ratio to one of four study conditions: low-load resistance training, moderate-load resistance training, high-load resistance training, or usual physical education. The three resistance-training conditions will differ primarily in training load, repetition range, number of sets, rest intervals, and repetitions in reserve.

The resistance-training program showing the highest frequency of beneficial individual responses in Cohort I will be selected for further evaluation. A beneficial individual response will be defined as an improvement exceeding the minimal detectable change (MDC) for the respective outcome. Cohort II will include a new set of school classes randomized in a 1:1 ratio to either the resistance-training program selected from Cohort I or usual physical education.

Randomization will be performed at the class level using permuted blocks. Block size will be four classes in Cohort I and two classes in Cohort II. The sex composition of classes will be considered to support balanced allocation across study conditions. The randomization sequence will be generated using R with a fixed random seed. Participants and physical education teachers cannot be blinded to group assignment. Outcome assessors will remain unaware of class allocation where feasible.

The resistance-training interventions will be incorporated into regular physical education lessons and supervised by physical education teachers. Exercises will use body weight, dumbbells, medicine balls, and resistance bands. Training load will progress every two weeks by modifying repetitions, rest intervals, external resistance, or the number of sets according to the assigned training condition.

Measurements will be performed at four time points: before the intervention, at the intervention midpoint, immediately after the eight-week intervention, and eight weeks after completion of the intervention. Assessments will include anthropometric measures, body composition assessed by bioelectrical impedance analysis, resting blood pressure, cardiorespiratory fitness assessed using the 20-m shuttle run test, handgrip strength, countermovement jump performance, standing long jump performance, 30-second sit-up performance, and 10-m sprint performance. Somatic maturation, injury history, dietary habits, rating of perceived exertion, and repetitions in reserve will also be recorded.

Statistical analyses will account for repeated measurements and the clustering of students within school classes. Mixed-effects approaches, including linear mixed models and generalized linear mixed models where appropriate, will be used to evaluate changes over time and differences between study groups. Individual responsiveness will additionally be evaluated using outcome-specific MDC thresholds.

Undersøgelsestype

Undersøgelsestype

Beskriver karakteren af ​​en klinisk undersøgelse. Undersøgelsestyper omfatter interventionelle undersøgelser (også kaldet kliniske forsøg), observationsundersøgelser (herunder patientregistre) og udvidet adgang.
Interventionel

Tilmelding (Anslået)

Tilmelding

Antallet af deltagere i en klinisk undersøgelse. Den "forventede" tilmelding er det mål for antallet af deltagere, som forskerne skal bruge til undersøgelsen.
264

Fase

Fase

Stadiet af et klinisk forsøg, der studerer et lægemiddel eller et biologisk produkt, baseret på definitioner udviklet af U.S. Food and Drug Administration (FDA). Fasen tager udgangspunkt i undersøgelsens formål, antallet af deltagere og andre karakteristika. Der er fem faser: Tidlig fase 1 (tidligere opført som fase 0), fase 1, fase 2, fase 3 og fase 4. Ikke relevant bruges til at beskrive forsøg uden FDA-definerede faser, herunder forsøg med enheder eller adfærdsmæssige indgreb.
  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Studiekontakt

Navn og kontaktoplysninger for den person, der kan besvare spørgsmål om tilmelding til en klinisk undersøgelse. Hvert sted, hvor undersøgelsen udføres, kan også have en specifik kontaktperson, som kan være bedre i stand til at besvare disse spørgsmål.

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Berettigelseskriterier

De nøglekrav, som personer, der ønsker at deltage i et klinisk studie, skal opfylde eller de egenskaber, de skal have. Kvalifikationskriterier består af både inklusionskriterier (som er nødvendige for at en person kan deltage i undersøgelsen) og eksklusionskriterier (som forhindrer en person i at deltage). Typer af berettigelseskriterier omfatter, om en undersøgelse accepterer raske frivillige, har alders- eller aldersgruppekrav eller er begrænset af køn.

Aldre berettiget til at studere

15 år til 18 år (Barn, Voksen)

Tager imod sunde frivillige

Ja

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Enrollment in the second year of a participating secondary school.
  • Participation in regular physical education lessons at the participating school.
  • No health contraindications to physical exercise.
  • Written informed consent from the participant and, for participants who are minors, written informed consent from a parent or legal guardian.

Exclusion Criteria:

  • Acute or chronic musculoskeletal injury preventing safe participation in the exercise intervention or physical fitness assessments.
  • Chronic disease or other medical condition constituting a contraindication to physical exercise.
  • Medical recommendation limiting participation in physical activity.
  • Acute infection or other temporary health condition preventing safe participation in a scheduled assessment.
  • Lack of the required informed consent.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Andet
  • Tildeling: Randomiseret
  • Interventionel model: Sekventiel tildeling
  • Maskning: Enkelt

Våben og indgreb

Deltagergruppe / Arm

Deltagergruppe / Arm

En gruppe eller undergruppe af deltagere i et klinisk forsøg, der modtager en specifik intervention/behandling eller ingen intervention i henhold til forsøgets protokol.
Intervention / Behandling

Intervention / Behandling

En proces eller handling, der er i fokus for en klinisk undersøgelse. Interventioner omfatter lægemidler, medicinsk udstyr, procedurer, vacciner og andre produkter, der enten er til undersøgelse eller allerede er tilgængelige. Interventioner kan også omfatte ikke-invasive tilgange, såsom uddannelse eller ændring af kost og motion.
Eksperimentel: Cohort I: Low-Load Resistance Training

Teacher-supervised resistance training incorporated into physical education lessons for eight weeks. Exercises use body weight, dumbbells, medicine balls, and resistance bands. The initial prescription consists of 2-3 sets of 12-15 repetitions, 30-40 seconds of rest between sets, and 3-4 repetitions in reserve. Training progresses every two weeks through planned changes in repetitions, rest intervals, external resistance, or number of sets.
Adfærdsmæssigt: Resistance training microdosing during physical education

Teacher-supervised resistance training incorporated into physical education over eight weeks using body weight, dumbbells, medicine balls, and resistance bands. Cohort I compares three prescriptions: low-load (2-3 sets, 12-15 repetitions, 30-40 s rest, 3-4 repetitions in reserve), medium-load (3-4 sets, 8-12 repetitions, about 60 s rest, 2-3 repetitions in reserve), and high-load (4-5 sets, 6-8 repetitions, about 90 s rest, 1-2 repetitions in reserve). Progression occurs every two weeks through changes in repetitions, rest, external resistance, or sets. Cohort II receives the program selected from Cohort I based on the frequency of improvements exceeding minimal detectable change.
Eksperimentel: Cohort I: Moderate-Load Resistance Training

Teacher-supervised resistance training incorporated into physical education lessons for eight weeks. Exercises use body weight, dumbbells, medicine balls, and resistance bands. The initial prescription consists of 3-4 sets of 8-12 repetitions, approximately 60 seconds of rest between sets, and 2-3 repetitions in reserve. Training progresses every two weeks through planned changes in repetitions, rest intervals, external resistance, or number of sets.
Adfærdsmæssigt: Resistance training microdosing during physical education

Teacher-supervised resistance training incorporated into physical education over eight weeks using body weight, dumbbells, medicine balls, and resistance bands. Cohort I compares three prescriptions: low-load (2-3 sets, 12-15 repetitions, 30-40 s rest, 3-4 repetitions in reserve), medium-load (3-4 sets, 8-12 repetitions, about 60 s rest, 2-3 repetitions in reserve), and high-load (4-5 sets, 6-8 repetitions, about 90 s rest, 1-2 repetitions in reserve). Progression occurs every two weeks through changes in repetitions, rest, external resistance, or sets. Cohort II receives the program selected from Cohort I based on the frequency of improvements exceeding minimal detectable change.
Eksperimentel: Cohort I: High-Load Resistance Training

Teacher-supervised resistance training incorporated into physical education lessons for eight weeks. Exercises use body weight, dumbbells, medicine balls, and resistance bands. The initial prescription consists of 4-5 sets of 6-8 repetitions, approximately 90 seconds of rest between sets, and 1-2 repetitions in reserve. Training progresses every two weeks through planned changes in repetitions, rest intervals, external resistance, or number of sets.
Adfærdsmæssigt: Resistance training microdosing during physical education

Teacher-supervised resistance training incorporated into physical education over eight weeks using body weight, dumbbells, medicine balls, and resistance bands. Cohort I compares three prescriptions: low-load (2-3 sets, 12-15 repetitions, 30-40 s rest, 3-4 repetitions in reserve), medium-load (3-4 sets, 8-12 repetitions, about 60 s rest, 2-3 repetitions in reserve), and high-load (4-5 sets, 6-8 repetitions, about 90 s rest, 1-2 repetitions in reserve). Progression occurs every two weeks through changes in repetitions, rest, external resistance, or sets. Cohort II receives the program selected from Cohort I based on the frequency of improvements exceeding minimal detectable change.
Ingen indgriben: Cohort I: Usual Physical Education

Students assigned to the control arm will continue their usual school physical education lessons for eight weeks and will not receive the study-specific resistance training microdosing intervention.
Eksperimentel: Cohort II: Selected Resistance Training Program

Teacher-supervised resistance training incorporated into physical education lessons for eight weeks. The program will be the low-, moderate-, or high-load resistance training protocol selected after completion of Cohort I according to the prespecified criterion of the highest frequency of beneficial individual responses exceeding the minimal detectable change in the assessed health-related fitness outcomes. The selected protocol will be implemented in a new set of school classes in Cohort II
Adfærdsmæssigt: Resistance training microdosing during physical education

Teacher-supervised resistance training incorporated into physical education over eight weeks using body weight, dumbbells, medicine balls, and resistance bands. Cohort I compares three prescriptions: low-load (2-3 sets, 12-15 repetitions, 30-40 s rest, 3-4 repetitions in reserve), medium-load (3-4 sets, 8-12 repetitions, about 60 s rest, 2-3 repetitions in reserve), and high-load (4-5 sets, 6-8 repetitions, about 90 s rest, 1-2 repetitions in reserve). Progression occurs every two weeks through changes in repetitions, rest, external resistance, or sets. Cohort II receives the program selected from Cohort I based on the frequency of improvements exceeding minimal detectable change.
Ingen indgriben: Cohort II: Usual Physical Education

New classes assigned to the control arm will continue their usual school physical education lessons for eight weeks and will not receive the study-specific resistance training microdosing intervention.

Hvad måler undersøgelsen?

Primære resultatmål

Primære resultatmål

I et klinisk studies protokol er det planlagte resultatmål, der er det vigtigste for at evaluere effekten af ​​en intervention/behandling. De fleste kliniske undersøgelser har ét primært resultatmål, men nogle har mere end ét.
Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Change in Body Fat Percentage
Tidsramme: Baseline, week 4, week 8, and week 16

Body fat percentage will be assessed using bioelectrical impedance analysis. Measurements will be obtained at baseline, week 4, week 8, and week 16. Change from baseline at each post-baseline assessment will be analyzed and expressed in percentage points.
Baseline, week 4, week 8, and week 16
Change in Muscle Mass
Tidsramme: Baseline, week 4, week 8, and week 16

Muscle mass will be assessed using bioelectrical impedance analysis. Measurements will be obtained at baseline, week 4, week 8, and week 16. Change from baseline at each post-baseline assessment will be analyzed.
Baseline, week 4, week 8, and week 16
Change in Systolic Blood Pressure
Tidsramme: Baseline, week 4, week 8, and week 16

Systolic blood pressure will be measured after five minutes of seated rest. Three measurements will be obtained at each assessment, and the mean of the three measurements will be used for analysis. Change from baseline at each post-baseline assessment will be analyzed.
Baseline, week 4, week 8, and week 16
Change in Diastolic Blood Pressure
Tidsramme: Baseline, week 4, week 8, and week 16

Diastolic blood pressure will be measured after five minutes of seated rest. Three measurements will be obtained at each assessment, and the mean of the three measurements will be used for analysis. Change from baseline at each post-baseline assessment will be analyzed.
Baseline, week 4, week 8, and week 16
Change in Estimated Maximal Oxygen Uptake
Tidsramme: Baseline, week 8

Cardiorespiratory fitness will be assessed using the 20-m shuttle run test. Maximal oxygen uptake (VO2max) will be estimated from test performance. Measurements will be obtained at baseline, week 4, week 8, and week 16, and change from baseline will be analyzed.
Baseline, week 8
Change in Handgrip Strength
Tidsramme: Baseline, week 4, week 8, and week 16

Isometric handgrip strength will be assessed using a handgrip dynamometer. Measurements will be obtained at baseline, week 4, week 8, and week 16. Change from baseline at each post-baseline assessment will be analyzed.
Baseline, week 4, week 8, and week 16
Change in Countermovement Jump Performance
Tidsramme: Baseline, week 4, week 8, and week 16

Vertical lower-limb power will be assessed using the countermovement jump. Jump height will be recorded at baseline, week 4, week 8, and week 16. Change from baseline at each post-baseline assessment will be analyzed.
Baseline, week 4, week 8, and week 16
Change in Standing Long Jump Performance
Tidsramme: Baseline, week 4, week 8, and week 16

Horizontal lower-limb power will be assessed using the standing long jump. Jump distance will be recorded at baseline, week 4, week 8, and week 16. Change from baseline at each post-baseline assessment will be analyzed.
Baseline, week 4, week 8, and week 16
Change in 30-Second Sit-Up Performance
Tidsramme: Baseline, week 4, week 8, and week 16

Trunk muscular endurance will be assessed using a 30-second sit-up test. The number of correctly completed repetitions will be recorded at baseline, week 4, week 8, and week 16. Change from baseline at each post-baseline assessment will be analyzed.
Baseline, week 4, week 8, and week 16
Change in 10-m Sprint Performance
Tidsramme: Baseline, week 4, week 8, and week 16

Locomotor speed and acceleration will be assessed using a 10-m sprint measured with photocells. Two trials will be performed, and the best performance will be used for analysis. Measurements will be obtained at baseline, week 4, week 8, and week 16, and change from baseline will be analyzed.
Baseline, week 4, week 8, and week 16

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Sponsor

Den organisation eller person, der igangsætter undersøgelsen, og som har myndighed og kontrol over undersøgelsen.
Wroclaw University of Health and Sport Sciences

Samarbejdspartnere

Samarbejdspartnere

En anden organisation end sponsoren, der yder støtte til en klinisk undersøgelse. Denne støtte kan omfatte aktiviteter relateret til finansiering, design, implementering, dataanalyse eller rapportering.
Ministry of Science and Higher Education, Poland

Efterforskere

Efterforskere

En forsker involveret i et klinisk studie. Beslægtede termer omfatter stedets principal investigator, site sub-investigator, studieformand, undersøgelsesleder og undersøgelseshovedinvestigator.
  • Ledende efterforsker: Dawid Koźlenia, PhD, Wroclaw University of Health and Sport Sciences

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Anslået)

Studiestart

Den faktiske dato, hvor den første deltager blev tilmeldt en klinisk undersøgelse. Den "forventede" undersøgelses startdato er den dato, som forskerne tror vil være undersøgelsens startdato.
1. november 2026

Primær færdiggørelse (Anslået)

Primær færdiggørelse

Den dato, hvor den sidste deltager i et klinisk studie blev undersøgt eller modtog en intervention for at indsamle endelige data for det primære resultatmål. Hvorvidt det kliniske studie sluttede i henhold til protokollen eller blev afsluttet, påvirker ikke denne dato. For kliniske undersøgelser med mere end ét primært resultatmål med forskellige afslutningsdatoer refererer dette udtryk til den dato, hvor dataindsamlingen er afsluttet for alle de primære resultatmål. Den "forventede" primære afslutningsdato er den dato, som forskerne tror vil være den primære afslutningsdato for undersøgelsen.
1. april 2028

Studieafslutning (Anslået)

Studieafslutning

Den dato, hvor den sidste deltager i et klinisk studie blev undersøgt eller modtog en intervention/behandling for at indsamle endelige data for de primære resultatmål, sekundære udfaldsmål og uønskede hændelser (det vil sige den sidste deltagers sidste besøg). Den "forventede" undersøgelses afslutningsdato er den dato, som forskerne tror vil være undersøgelsens afslutningsdato.
1. april 2028

Datoer for studieregistrering

Først indsendt

Først indsendt

Den dato, hvor undersøgelsens sponsor eller investigator første gang indsendte en undersøgelsespost til ClinicalTrials.gov. Der er typisk en forsinkelse på et par dage mellem den første indsendte dato og postens tilgængelighed på ClinicalTrials.gov (den første offentliggjorte dato).
21. september 2026

Først indsendt, der opfyldte QC-kriterier

Først indsendt, der opfyldte QC-kriterier

Den dato, hvor undersøgelsens sponsor eller investigator første gang indsender en undersøgelsespost, der er i overensstemmelse med National Library of Medicine (NLM) kvalitetskontrol (QC) gennemgangskriterier. Sponsoren eller investigatoren skal muligvis revidere og indsende en undersøgelsespost en eller flere gange, før NLM's kvalitetskontrolkriterier er opfyldt. Det er sponsorens eller investigatorens ansvar at sikre, at undersøgelsesposten er i overensstemmelse med NLM QC-gennemgangskriterierne.
21. september 2026

Først opslået (Faktiske)

Først opslået

Datoen, hvor undersøgelsesposten først var tilgængelig på ClinicalTrials.gov efter National Library of Medicine (NLM) kvalitetskontrol (QC) gennemgang er afsluttet. Der er typisk en forsinkelse på et par dage mellem den dato, hvor undersøgelsens sponsor eller investigator indsendte undersøgelsesposten, og den første offentliggjorte dato.
29. september 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

Sidste opdatering sendt

Den seneste dato, hvor ændringer i en undersøgelsespost blev gjort tilgængelig på ClinicalTrials.gov. Der kan være en forsinkelse mellem det tidspunkt, hvornår ændringerne blev indsendt til ClinicalTrials.gov af undersøgelsens sponsor eller investigator (datoen for sidste opdatering afsendt) og den sidste opdatering, der blev sendt.
29. september 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

Den seneste dato, hvor undersøgelsens sponsor eller investigator indsendte ændringer til en undersøgelsespost, der er i overensstemmelse med National Library of Medicine (NLM) kvalitetskontrol (QC) gennemgangskriterier. Det er sponsorens eller investigatorens ansvar at sikre, at undersøgelsesposten er i overensstemmelse med NLM QC-gennemgangskriterierne.
21. september 2026

Sidst verificeret

Sidst verificeret

Den seneste dato, hvor undersøgelsens sponsor eller investigator bekræftede oplysningerne om en klinisk undersøgelse på ClinicalTrials.gov som nøjagtige og aktuelle. Hvis en undersøgelse med rekrutteringsstatus som rekruttering; rekrutterer endnu ikke; eller aktiv, ikke rekruttering er ikke blevet bekræftet inden for de seneste 2 år, er undersøgelsens rekrutteringsstatus vist som ukendt.
1. september 2026

Mere information

Begreber relateret til denne undersøgelse

Nøgleord

Andre undersøgelses-id-numre

Andre undersøgelses-id-numre

Andre identifikatorer eller ID-numre end NCT-nummeret, der er tildelt til en klinisk undersøgelse af undersøgelsens sponsor, finansieringsgivere eller andre. Disse numre kan omfatte unikke identifikatorer fra andre forsøgsregistre og National Institutes of Health-bevillingsnumre.
  • NdRS/SP/0160/2025/01
  • NdRS/SP/0160/2025/01 (Andet bevillings-/finansieringsnummer: inistry of Science and Higher Education, Poland)

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

JA

IPD-planbeskrivelse

De-identified individual participant data underlying the results reported in study publications may be shared with qualified researchers upon reasonable request to the Principal Investigator, subject to applicable data protection regulations, institutional requirements, and the conditions of informed consent. No directly identifiable participant information will be shared.

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Cookieindstillinger

Vi bruger cookies for at sikre, at vi giver dig den bedste oplevelse på vores hjemmeside. For flere detaljer skal du læse omhyggeligt vores Politik om beskyttelse af personlige oplysninger og cookies. ...>>>Du kan når som helst ændre dine præferencer eller trække dit samtykke tilbage ved at slette cookies fra din hjemmeside eller computer som beskrevet i politikken. Accepter det og vælg dine præferencer ved at markere de tilsvarende felter i afsnittet "Administrer indstillinger" nedenfor. Læs vores servicevilkår omhyggeligt, inden du fortsætter med at bruge nogen del af dette websted.
«Administrer indstillinger